Identification of a peripheral blood transcriptional biomarker panel associated with operational renal allograft tolerance
- 25 September 2007
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 104 (39), 15448-15453
- https://doi.org/10.1073/pnas.0705834104
Abstract
Long-term allograft survival generally requires lifelong immunosuppression (IS). Rarely, recipients display spontaneous “operational tolerance” with stable graft function in the absence of IS. The lack of biological markers of this phenomenon precludes identification of potentially tolerant patients in which IS could be tapered and hinders the development of new tolerance-inducing strategies. The objective of this study was to identify minimally invasive blood biomarkers for operational tolerance and use these biomarkers to determine the frequency of this state in immunosuppressed patients with stable graft function. Blood gene expression profiles from 75 renal-transplant patient cohorts (operational tolerance/acute and chronic rejection/stable graft function on IS) and 16 healthy individuals were analyzed. A subset of samples was used for microarray analysis where three-class comparison of the different groups of patients identified a “tolerant footprint” of 49 genes. These biomarkers were applied for prediction of operational tolerance by microarray and real-time PCR in independent test groups. Thirty-three of 49 genes correctly segregated tolerance and chronic rejection phenotypes with 99% and 86% specificity. The signature is shared with 1 of 12 and 5 of 10 stable patients on triple IS and low-dose steroid monotherapy, respectively. The gene signature suggests a pattern of reduced costimulatory signaling, immune quiescence, apoptosis, and memory T cell responses. This study identifies in the blood of kidney recipients a set of genes associated with operational tolerance that may have utility as a minimally invasive monitoring tool for guiding IS titration. Further validation of this tool for safe IS minimization in prospective clinical trials is warranted.This publication has 55 references indexed in Scilit:
- Banff ’05 Meeting Report: Differential Diagnosis of Chronic Allograft Injury and Elimination of Chronic Allograft Nephropathy (’CAN’)American Journal of Transplantation, 2007
- Multiparameter Immune Profiling of Operational Tolerance in Liver TransplantationAmerican Journal of Transplantation, 2007
- Noninvasive Discrimination of Rejection in Cardiac Allograft Recipients Using Gene Expression ProfilingAmerican Journal of Transplantation, 2005
- TGF-β Targets the Wnt Pathway Components, APC and β-catenin, as Mv1Lu Cells Undergo Cell Cycle ArrestCell Cycle, 2004
- Differences in lymphocyte gene expression between tolerant and syngeneic liver grafted ratsLiver Transplantation, 2004
- Frontline: Neuropilin‐1: a surface marker of regulatory T cellsEuropean Journal of Immunology, 2004
- Downregulation of a rheumatoid arthritis-related antigen (RA-A47) by ra-a47 antisense oligonucleotides induces inflammatory factors in chondrocytesJournal of Cellular Physiology, 2003
- Stereotyped and specific gene expression programs in human innate immune responses to bacteriaProceedings of the National Academy of Sciences of the United States of America, 2002
- TGF-β1 and donor dendritic cells are common key components in donor-specific blood transfusion and anti-class II heart graft enhancement, whereas tolerance induction also required inflammatory cytokines down-regulationEuropean Journal of Immunology, 2001
- The Banff 97 working classification of renal allograft pathologyKidney International, 1999